4.5 Article

The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation

Related references

Note: Only part of the references are listed.
Review Oncology

Management of locally advanced breast cancer-perspectives and future directions

Konstantinos Tryfonidis et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2015)

Article Oncology

Current Clinical Trials Testing Combinations of Immunotherapy and Radiation

Mario Crittenden et al.

SEMINARS IN RADIATION ONCOLOGY (2015)

Review Biochemistry & Molecular Biology

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

L. Galluzzi et al.

CELL DEATH AND DIFFERENTIATION (2015)

Review Oncology

Influence of Lifestyle Factors on Breast Cancer Risk

Max Dieterich et al.

BREAST CARE (2014)

Article Toxicology

Norm-and hypo-fractionated radiotherapy is capable of activating human dendritic cells

Lorenz Kulzer et al.

JOURNAL OF IMMUNOTOXICOLOGY (2014)

Editorial Material Oncology

How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?

William F. Anderson et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Editorial Material Oncology

Immunological aspects of radiotherapy

Heike Scheithauer et al.

RADIATION ONCOLOGY (2014)

Article Oncology

Molecular Heterogeneity of Triple-Negative Breast Cancer

Vandana G. Abramson et al.

CURRENT BREAST CANCER REPORTS (2014)

Article Oncology

Breast Radiotherapy: Less is More?

C. E. Coles et al.

CLINICAL ONCOLOGY (2013)

Review Oncology

Electrochemotherapy of chest wall breast cancer recurrence

Gregor Sersa et al.

CANCER TREATMENT REVIEWS (2012)

Review Cell Biology

Hsp70, a messenger from hyperthermia for the immune system

Anna Jolesch et al.

EUROPEAN JOURNAL OF CELL BIOLOGY (2012)

Article Oncology

Old and new facts about hyperthermia-induced modulations of the immune system

Benjamin Frey et al.

INTERNATIONAL JOURNAL OF HYPERTHERMIA (2012)

Review Oncology

Dying cell clearance and its impact on the outcome of tumor radiotherapy

Kirsten Lauber et al.

FRONTIERS IN ONCOLOGY (2012)

Editorial Material Oncology

The Challenge of Integrating Radiotherapy in the Multimodal Treatment of Breast Cancer

Rainer Souchon et al.

BREAST CARE (2011)

Article Oncology

Triple-Negative Breast Cancer: An Unmet Medical Need

Clifford A. Hudis et al.

ONCOLOGIST (2011)

Article Oncology

DNA Repair Targeting and Radiotherapy: A Focus on the Therapeutic Ratio

John Thoms et al.

SEMINARS IN RADIATION ONCOLOGY (2010)

Review Biochemistry & Molecular Biology

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

L. Galluzzi et al.

CELL DEATH AND DIFFERENTIATION (2009)

Review Biochemistry & Molecular Biology

Molecular characteristics of immunogenic cancer cell death

A. Tesniere et al.

CELL DEATH AND DIFFERENTIATION (2008)

Article Oncology

Hyperthermia: a potent enhancer of radiotherapy

M. R. Horsman et al.

CLINICAL ONCOLOGY (2007)

Article Biochemistry & Molecular Biology

Caspase independence of radio-induced cell death

P. Zhang et al.

ONCOGENE (2006)

Review Cell Biology

Apoptosis-inducing factor: vital and lethal

Nazanine Modjtahedi et al.

TRENDS IN CELL BIOLOGY (2006)

Article Biochemical Research Methods

Analysis of apoptosis by propidium iodide staining and flow cytometry

Carlo Riccardi et al.

NATURE PROTOCOLS (2006)

Article Oncology

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

S Demaria et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)

Review Oncology

Relevance of breast cancer cell lines as models for breast tumours: an update

M Lacroix et al.

BREAST CANCER RESEARCH AND TREATMENT (2004)

Article Biochemistry & Molecular Biology

Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death

US Gaipl et al.

CELL DEATH AND DIFFERENTIATION (2001)

Article Oncology

Local hyperthermia, radiation, and chemotherapy in recurrent breast cancer is feasible and effective except for inflammatory disease

T Feyerabend et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)